• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Three-T MRI enhances diagnosis of focal epilepsy

Publication
Article
Diagnostic ImagingDiagnostic Imaging Vol 30 No 11
Volume 30
Issue 11

A recent study at the Oregon Health and Science University in Portland has confirmed that 3T MR imaging improves on 1.5T MRI for detecting and characterizing struc-tural brain abnormalities in patients with focal epilepsy.

A recent study at the Oregon Health and Science University in Portland has confirmed that 3T MR imaging improves on 1.5T MRI for detecting and characterizing struc-tural brain abnormalities in patients with focal epilepsy.

Surgery can cure focal epilepsy, but only patients with a specific imaging-diagnosed structural brain abnormality are candidates for the treatment. An accurate, one-go MRI exam is thus preferable since insurance companies may not pay for a second one, according to sen-ior investigator Dr. Bronwyn E. Hamilton.

Hamilton and colleagues evaluated 74 epilepsy cases. The researchers detected brain abnormalities in 65 patients using 3T MRI compared with 55 detected by 1.5T MRI. Investigators also found 3T MRI accurately characterized lesions in 63 cases, compared with 51 for 1.5T scanning (AJR 2008; 191:890-895).

Recent Videos
2 KOLs are featured in this series.
2 KOLs are featured in this series.
2 KOLs are featured in this series.
2 KOLs are featured in this series.
Detecting PCa Recurrence in African Americans: Can 18F-Flotufolastat Have an Impact?
Emerging Research at SNMMI Examines 18F-flotufolastat in Managing Primary and Recurrent Prostate Cancer
Could Pluvicto Have a Role in Taxane-Naïve mCRPC?: An Interview with Oliver Sartor, MD
New SNMMI President Cathy Cutler, PhD, Discusses Current Challenges and Goals for Nuclear Medicine
Where the USPSTF Breast Cancer Screening Recommendations Fall Short: An Interview with Stacy Smith-Foley, MD
A Closer Look at MRI-Guided Transurethral Ultrasound Ablation for Intermediate Risk Prostate Cancer
Related Content
© 2024 MJH Life Sciences

All rights reserved.